Trial of nasal influenza vaccine expands.
Veggeberg
S
S
D000281:Administration, Intranasal; D002648:Child; D002675:Child, Preschool; D017326:Clinical Trials, Phase III as Topic; D018849:Controlled Clinical Trials as Topic; D006801:Humans; D007223:Infant; D007252:Influenza Vaccines / Q000008:administration & dosage*; D007251:Influenza, Human / Q000517:prevention & control*; D009316:National Institutes of Health (U.S.); D014481:United States; D014486:United States Food and Drug Administration; D014613:Vaccines, Attenuated / Q000008:administration & dosage
D007252:Influenza Vaccines; D014613:Vaccines, Attenuated